Drug Shortage Report for LEVETIRACETAM
Report ID | 77536 |
Drug Identification Number | 02454653 |
Brand name | LEVETIRACETAM |
Common or Proper name | LEVETIRACETAM |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 120 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-03-01 |
Estimated end date | 2020-03-09 |
Actual end date | 2020-05-28 |
Shortage status | Resolved |
Updated date | 2020-05-29 |
Company comments | Product to be discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-05-29 | French | Compare |
v9 | 2020-05-29 | English | Compare |
v8 | 2019-09-12 | French | Compare |
v7 | 2019-09-12 | English | Compare |
v6 | 2019-06-11 | French | Compare |
v5 | 2019-06-11 | English | Compare |
v4 | 2019-05-09 | French | Compare |
v3 | 2019-05-09 | English | Compare |
v2 | 2019-03-04 | French | Compare |
v1 | 2019-03-04 | English | Compare |
Showing 1 to 10 of 10